CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
39.41
-0.49 (-1.23%)
At close: Mar 9, 2026, 4:00 PM EDT
39.41
0.00 (0.00%)
After-hours: Mar 9, 2026, 7:00 PM EDT
CONMED Revenue
In the year 2025, CONMED had annual revenue of $1.37B with 5.18% growth. CONMED had revenue of $373.20M in the quarter ending December 31, 2025, with 7.88% growth.
Revenue (ttm)
$1.37B
Revenue Growth
+5.18%
P/S Ratio
0.88
Revenue / Employee
$352,493
Employees
3,900
Market Cap
1.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.37B | 67.71M | 5.18% |
| Dec 31, 2024 | 1.31B | 62.27M | 5.00% |
| Dec 31, 2023 | 1.24B | 199.27M | 19.06% |
| Dec 31, 2022 | 1.05B | 34.84M | 3.45% |
| Dec 31, 2021 | 1.01B | 148.18M | 17.18% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.24B |
| QuidelOrtho | 2.73B |
| Enovis | 2.25B |
| Tandem Diabetes Care | 1.01B |
| NovoCure | 655.35M |
| UFP Technologies | 602.80M |
| PROCEPT BioRobotics | 308.05M |
| Axogen | 225.21M |
CNMD News
- 5 weeks ago - CONMED Corporation (CNMD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results - Business Wire
- 7 weeks ago - CONMED Corporation (CNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - CONMED Corporation Announces Chief Financial Officer Transition - Business Wire
- 2 months ago - CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - CONMED Corporation to Announce Fourth Quarter 2025 Financial Results on January 28, 2026 - Business Wire
- 3 months ago - CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines - Business Wire
- 4 months ago - CONMED Corporation (CNMD) Q3 2025 Earnings Call Transcript - Seeking Alpha